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Preincubation of rat renal mesangial cells with 12-0-tetradecanoylphorbol 13-acetate (TPA) strongly inhib- 
ited the increases of inositol phosphates and of free cytosolic Ca *+ induced by angiotensin II (lo-’ M). TPA 
had no significant effect on the basal values of inositol phosphates and of free cytosolic Caz+. Inhibition 
appeared already after 1 min and was maximal after 5 min. These effects occur without significant changes 
on angiotensin II binding in intact cells. The concentration of TPA needed (lO-g-lO-7 M) was in the range 
believed to cause specifically an activation of protein kinase C. Furthermore the biologically inactive phor- 
bol ester 4a-phorbol 12,13-didecanoate was without effect. From the entirety of these results it is likely that 
protein kinase C inhibits angiotensin II activation of phospholipase C at a stage distal to receptor occupan- 
cy. 
Angiotensin II Inositol trisphosphate 
1. INTRODUCTION 
A causal relationship between phosphoinositide 
turnover and Ca*+ mobilization induced by a 
number of hormones was first suggested by 
Michell in 1975 [I 1. The mechanism, however, by 
which agonists mobilize Ca*+ was unclear for 
many years. Recently it has become evident that 
most agonists mobilize Ca*+ by stimulating the 
hydrolysis of phosphatidylinositol 4,5bisphos- 
phate (PIP*) in the plasma membrane. A phospho- 
lipase C cleaves PIP2 to yield inositol trisphosphate 
Abbreviations: TPA, 12-0-tetradecanoylphorbol 13- 
acetate; PIPI, phosphatidylinositol 4,5-bisphosphate; 
IP3, myo-inositol trisphosphate; IPz, myo-inositol 
bisphosphate; IPi, myo-inositol monophosphate; DC, 
1,2-diacylglycerol; quin 2/AM, 2-[(2-bis(carboxyme- 
thyl)amino-5-methylphenoxy)methyl]-6-methoxy-8-bis- 
(carboxymethyl)aminoquinoline t trakis(acetoxymethy1) 
ester 
Ca2+ Phorbol ester Protein kinase C 
(IP3) and 1,2-diacylglycerol (DG) [2]. The IP3 thus 
produced has been demonstrated to release Ca*+ 
from the endoplasmic reticulum and DG activates 
protein kinase C which in turn phosphorylates 
various cellular proteins [3,4]. There is good 
evidence that protein kinase C and cytosolic free 
Ca*+ may act independently or synergistically to 
initiate a wide variety of metabolic reactions [5]. 
Recent studies, however, have demonstrated that 
several agonist-induced processes in different cell 
types can be inhibited by preincubation with 
tumour-promoting phorbol esters, suggesting a 
role for protein kinase C as a negative feedback 
regulator of cell function [6-l 11. 
Previously I have shown that vasoconstrictive 
hormones, like angiotensin II, arginine vasopressin 
or noradrenaline activate a phospholipase C in rat 
renal mesangial cells, thereby causing increased 
phosphoinositide hydrolysis and IP3 and DG for- 
mation [ 12,131. Both cleavage products play an im- 
portant role in cellular responses in mesangial 
262 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 
Volume 203, number 2 FEBS LETTERS July 1986 
cells, especially in prostaglandin synthesis. Here, I 
used the mesangial ceils to determine if phospho- 
inositide metabolism of Ca2+ mobilization are 
altered when 12-0-tetradecanoylphorbol 13-ace- 
tate (TPA) is used to activate protein kinase C. I 
report that pretreatment with TPA inhibits an- 
giotensin II-stimulated IF$ formation and Ca2+ 
mobilization in mesangial cells. These effects occur 
independently of significant changes in [‘251]angio- 
tensin II binding capacity or affinity in intact cells. 
2. EXPERIMENTAL 
2.1. Materials 
Angiotensin II, TPA and 4cy-phorbol 12,13-di- 
decanoate were from Sigma. 1 -Oleoyl-2-acetyl- 
glycerol was from Molecular Probes. myo-[2-3H]- 
Inositol was purchased from Amersham Interna- 
tional. [tyrosyl-12’I]Angiotensin II was purchased 
from New England Nuclear. Quin 2/AM was from 
Calbiochem and all other chemicals from Merck. 
2.2. Cell culture 
Cultivation of rat mesangial cells was done as 
described [141. For all experiments the first passage 
of mesangial cells was used. The cells were grown 
in RPM1 1640 (Boehringer) supplemented with 
10% fetal bovine serum (Boehringer), penicillin 
(100 U/ml), streptomycin (100 rg/ml) (Boeh- 
ringer) and bovine insulin at 0.66 U/ml (Sigma). 
Cells were incubated in a humidified atmosphere in 
incubators in air/CO2 (19: 1). 
2.3. Measurement of [Ca”Ji 
[Ca2+]i was measured by using the fluorescent 
calcium indicator quin 2 as described [151. In brief: 
about 2 x 10’ cells were incubated with 25 /IM 
quin 2/AM in RPM1 1640 for 20 min followed by 
another 40 min incubation with 4 vols of the 
medium. After the incubation period, aliquots of 
1 x lo6 cells were washed twice and resuspended in 
Hepes-buffered saline containing 1.3 mM Ca2+. 
Fluorescence of quin 2-loaded cells was measured 
at 37°C in a Shimadzu RF-510 spectrofluoropho- 
tometer using an excitation wavelength of 340 nm 
and emission wavelength of 492 nm. The fluo- 
rescence signal was calibrated at the end of each in- 
dividual trace essentially as described by Tsien et 
al. [16]. 
2.4. Determination of inositol phosphates 
Mesangial cells were prelabelled for 2 x 72 h 
with myo-[2-3H]inositol (10 &i/ml) in MEM con- 
taining 10% dialysed fetal bovine serum. After the 
prelabelling period the medium was removed and 
the cells rinsed several times to remove free 13H]- 
inositol. After this procedure cells were incubated 
for 5 min in 1 ml MEM with TPA or vehicle. 
Thereafter angiotensin II (lo-’ M) was added. 
After 10 s the medium was aspirated and the reac- 
tions terminated by the addition of 1 ml of 15% 
(w/v) trichloroacetic acid. The different inositol 
phosphates were separated by anion-exchange 
chromatography on Dowex 1 X8 as in [ 131. 
2.5. Angiotensin II binding assay 
Binding experiments were done using dissociated 
cells scraped off the flasks as described [ 151. In 
brief: [1251]angiotensin II was added at 0.5 nM and 
incubated with 30-40 pg cellular protein per tube 
at room temperature for 40 min. At the end of the 
incubation, bound radioactivity was separated 
through a Millipore filter (0.22 ,um GS). An ali- 
quot of the cell suspension was used for protein 
determination [171. Specific binding was calculated 
by subtracting the binding in the presence of 5 FM 
Table 1 
Effect of TPA and 1-oleoyl-2-acetylglycerol on
angiotensin II-induced formation of inositol phosphates 
Addition 3H radioactivity 
(cpm/mg protein) in 
IPI IP2 Ips 
Control 1762 f 115 557 f 38 528 f 43 
Angiotensin II 3172 f 242 1437 k 95 1146 f 52 
TPA 1812 f 95 538 f 22 540 f 37 
Angiotensin II + 
TPA 2150 f 212 796 k 64 614 f 34 
OAG 1822 + 152 573 f 44 552 f 63 
Angiotensin II + 
OAG 2413 f 203 895 f 63 722 f 43 
Mesangial cells were prelabelled with myo-[‘H)inositol, 
treated with TPA (lo-’ M, 5 min). 1-oleoyl-2- 
acetylglycerol (OAG) (5 x 10m6 M, 5 min) or vehicle and 
then exposed to angiotensin II (lo-’ M) for 10 s. Data 
are means f SE of 4 experiments 
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unlabelled angiotensin II from total binding and 
expressed as fmol bound angiotensin II/mg cell 
protein. 
3. RESULTS 
Stimulation of mesangial cells prelabelled with 
[3H]inositol with angiotensin II (lo-’ M) for 10 s 
caused a significant increase in formation of IP1 
(+ 80%), IP2 (+ 158%) as well as IP3 (+ 117%) 
(table 1). Preincubation of mesangial cells for 
5 min with TPA (lo-’ M) had no significant effect 
on the basal inositol phosphates but nearly totally 
inhibited angiotensin II-induced increases in IPi, 
IP2 and also IP3 (table 1). This effect of TPA was 
dose-dependent (fig. 1, upper) and also dependent 
on the preincubation time (fig. 1, lower). The non- 
3 
i 80 
23 
.g 60 I 
l TPA 
o 4 ti -Phorbol- 
$l dldecanoate 
- 0 
P 10-g -8 10-7 
% (MI lo 
01, , / 1 
0 1 2 5 10 
Time of TPA pretreatement (mm) 
Fig.1. Time and dose dependency of inhibition of 
angiotensin II-induced IP3 formation by TPA or 4cu- 
phorbol 12,13_didecanoate. Values are means from 3-4 
experiments k SE. 
tumour-promoting 4cu-phorbol 12,13-didecanoat 
had no effect on angiotensin II-stimulated IP3 for 
mation as shown in fig.1. The synthetic DC 
analogue 1-oleoyl-2-acetylglycerol a so significant- 
ly inhibited the angiotensin II-induced inositol 
phosphate production (table 1). Using quin 2- 
labelled mesangial cells, suspended in a medium of 
[Ca”], = 1.3 mM, angiotensin II (lo-’ M) caused 
an elevation of [Ca’+]i from a resting value of 199 
+ 4 nM (mean + SE, n = 17) to a maximum of 382 
+ 41 nM (mean k SE, n = 9). Pretreatment with 
TPA (lo-’ M, 5 min) did not alter the basal level 
of [Ca*+]i: 192 + 15 nM (mean + SE, n = 5) but 
dose- and time-dependently inhibited the angioten- 
sin II-stimulated increase in [Ca”], (figs 2,3). The 
biologically inactive k-phorbol 12,13-didecanoate 
was without effect (fig.3). 
To exclude the possibility that TPA-induced at- 
tenuation of the angiotensin II effects is due to 
decreased density or affinity of receptors on 
mesangial cells we determined the specific binding 
of [‘*‘I]angiotensin. The specific binding of 
[‘*‘I]angiotensin II to intact mesangial cells was 
[ 1 Ca*+ i 500 nM - 
250nM- 
150nM- 
DMSO A II 
(10-7M) 
250 nM- 
150 nM- 
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w 
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- 
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Fig.2. Effect of TPA on angiotensin II-induced increases 
in [Ca*+], as indicated by quin 2 fluorescence. 
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Fig.3. Time and dose dependency of inhibition of 
angiotensin II-induced increases in [Ca2”]i by TPA or 
&-phorbol 12,13-didecanoate. Values are means from 
3-17 experiments f SE. 
plotted as a function of the concentration of the 
labelled hormone. A linear curve was obtained cor- 
responding to one group of receptor sites. The 
maximal binding sites (39 fmol/mg protein) and 
the apparent dissociation constant & (2.1 nM) 
were calculated. There was no significant dif- 
ference in either the number of binding sites or 
their affinities for angiotensin II between control 
cells and cells treated with TPA (lo-’ M) for 
5 min. 
4. DISCUSSION 
The inhibition of angiotensin II-induced PIP2 
hydrolysis and [Ca”]i rise by TPA in mesangial 
cells occurred at the low concentrations of the 
phorbol ester which are thought to be specific for 
activation of protein kinase C. Also, the effect of 
I-oleoyl-2-acetylglycerol on angiotensin II-sti- 
mulated IP3 formation and the ineffectiveness 
of 4cY-phorbol 12,13-didecanoate suggest that 
phosphorylations by protein kinase C might 
mediate these effects of TPA. Our results indicate 
that TPA did not modulate the binding properties 
of the angiotensin II receptor in cultured mesangial 
cells. This is in contrast to observations reporting 
that phorbol esters decrease either the binding 
capacity or the affinity for several hormones, in- 
cluding cri-adrenergic ligands in hepatocytes 191, 
somatostatin binding in GH3 pituitary cells [I81 
and insulin in cultured blood cells and fibroblasts 
[19,20]. On the other hand, the binding of vaso- 
pressin in hepatocytes [9], of jet-Leu-Phe in 
neutrophils [S], of insulin in hepatoma cells [Zl] 
and of angiotensin II in vascular smooth muscle 
cells [1 1] is unaffected by TPA. In the latter cells 
as well as in mesangial cells the inhibition induced 
by TPA occurred at a stage distal to receptor oc- 
cupancy. The mechanism underlying these in- 
hibitory effects of TPA has not been defined 
directly. 
Recently, I have shown that a G-protein is likely 
to be involved in coupling of angiotensin II recep- 
tor to phospholipase C activation in mesangial 
cells 1151. Pretreatment of mesangial cells with 
Bordetella pertussis toxin inhibits angiotensin II- 
stimulated effects in mesangial cells. There are 
striking similarities in the action of TPA and per- 
tussis toxin in mesangial cells: both inhibit dose- 
and time-dependently phosphoinositide hydrolysis 
and [Ca2+]i rises without affecting angiotensin II 
binding to intact mesangial cells, Therefore it is 
tempting to speculate that TPA and pertussis toxin 
may have the same target, i.e. a G-protein coupling 
angiotensin II receptors to phospholipase C. Per- 
tussis toxin encouples the receptor by ADP- 
ribosylation of this G-protein [IS] and TPA ac- 
tivates protein kinase C which perhaps phos- 
phorylates and thereby also inactivates this G- 
protein. In addition, Katada et al. 1221 have 
demonstrated that protein kinase C is able to 
phosphorylate the inhibitory guanine-nucleotide- 
binding regulatory component of adenylate cy- 
clase, thereby suppressing its function. Garrison et 
al. [23] have reported that phorbol esters increase 
the phosphorylation of a 35 kDa protein which is 
also phosphorylated by angiotensin II. Interesting- 
ly, this protein is of similar size to the-subunit of 
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G, and Gi in the adenylate cyclase system [24]. 
Such a modulation of signal transduction in 
calcium-mobilizing cells by protein kinase C at the 
level of regulatory G-proteins would also explain 
the observed heterologous desensitization of 
angiotensin II by arginine vasopressin in mesangial 
cells (Pfeilschifter, J., unpublished). 
I am currently trying to characterize further the 
possible target substrate of protein kinase C which 
enables the enzyme to play a dual role in cellular 
activation: not only to mediate but also to ter- 
minate cellular responsiveness initiated by ex- 
posure to agonists. 
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